Consainsights logo
Mail Us
Reports > Life Sciences > Animal Model Market Report

Animal Model Market Size, Share, Industry Trends and Forecast to 2033

This report provides comprehensive insights into the Animal Model market, covering market size, growth trends, and detailed analyses from 2023 to 2033. Key data, industry dynamics, and forecasts will enable stakeholders to make informed decisions.

Metric Value
Study Period 2023 - 2033
2023 Market Size $14.30 Billion
CAGR (2023-2033) 9.2%
2033 Market Size $35.53 Billion
Top Companies Charles River Laboratories, Janvier Labs, Envigo, Taconic Biosciences
Last Modified Date 15 Nov 2024

Animal Model Market Report (2023 - 2033)

Animal Model Market Overview

The Animal Model industry is witnessing robust growth propelled by technological advancements and an increasing number of regulatory guidelines emphasizing the need for animal studies in drug development. The industry comprises biopharmaceutical companies, academic institutions, and contract research organizations (CROs). Factors such as globalization of clinical trials and shifting trend towards personalized medicine have compelled industry players to innovate. Additionally, the advent of CRISPR technology for gene editing has opened new avenues in model development, creating specialized animals that more accurately resemble human diseases, thus accelerating the drug discovery process.

What is the Market Size & CAGR of Animal Model market in 2023?

As of 2023, the Animal Model market size is approximately $22.5 billion, with a projected compound annual growth rate (CAGR) of about 9.2% from 2023 to 2033. The market’s growth is driven by increasing R&D activities in biopharmaceuticals, a surge in chronic diseases necessitating innovative therapies, and a strong emphasis on preclinical testing to mitigate drug failure rates. Furthermore, the rise of precision medicine and genetically modified organisms has sparked demand in segments focusing on specific disease models, enhancing the overall market potential.

Animal Model Industry Analysis

The Animal Model industry is witnessing robust growth propelled by technological advancements and an increasing number of regulatory guidelines emphasizing the need for animal studies in drug development. The industry comprises biopharmaceutical companies, academic institutions, and contract research organizations (CROs). Factors such as globalization of clinical trials and shifting trend towards personalized medicine have compelled industry players to innovate. Additionally, the advent of CRISPR technology for gene editing has opened new avenues in model development, creating specialized animals that more accurately resemble human diseases, thus accelerating the drug discovery process.

Animal Model Market Segmentation and Scope

The Animal Model market is segmented by species type, model type, end-users, and application areas. By species, the major categories include rodents and non-rodents. By model type, the segmentation includes genetically modified models, wild-type models, and syndromic models. Key end-users of these models are pharmaceutical companies, academic institutions, and CROs, each with distinctive needs tailored to specific research areas. Application areas encompass oncology, neurology, immunology, and toxicology among others. This segmentation underscores the diverse utility of animal models across different fields of research and development.

Request a custom research report for industry.

Animal Model Market Analysis Report by Region

Europe Animal Model Market Report:

Europe, with a market size starting at $4.47 billion in 2023, aims for $11.10 billion by 2033. The growth is propelled by increasing government funding and a strong presence of leading pharmaceutical companies. Moreover, efforts to comply with animal welfare laws impact model selection effectively.

Asia Pacific Animal Model Market Report:

The Asia Pacific market is expected to grow from $3.08 billion in 2023 to $7.65 billion by 2033, driven by increased investments in biopharmaceuticals and rising demand for advanced research facilities. Countries like China and India are becoming hubs for R&D due to lower operational costs and a growing pool of skilled professionals, thus attracting foreign investments.

North America Animal Model Market Report:

North America dominated the market with a size of $4.60 billion in 2023, anticipated to reach $11.42 billion by 2033. This region is characterized by significant investment in biotechnology and pharmaceuticals, along with stringent regulations ensuring the safety and efficacy of products developed using animal models, driving a higher demand.

South America Animal Model Market Report:

In South America, the market is projected to increase from $0.53 billion in 2023 to $1.33 billion by 2033. Growth in this region is fueled by enhancing regulatory frameworks and increased collaboration between local institutions and global pharmaceutical companies. However, technological adoption remains a challenge due to resource constraints.

Middle East & Africa Animal Model Market Report:

The Middle East and Africa market is expected to grow from $1.63 billion in 2023 to $4.04 billion by 2033, supported by boosting investments in scientific research and healthcare. Collaboration between Europe and the Middle Eastern countries seeks to develop markets that adhere to global standards of animal research.

Request a custom research report for industry.

Animal Model Market Analysis By Species

Global Animal Model Market, By Species Market Analysis (2023 - 2033)

In 2023, rodent models account for a significant market share of 86.28% amounting to $12.34 billion, expected to rise to $30.65 billion by 2033. Non-rodent models currently represent 13.72% of the market, valued at $1.96 billion, with a forecast of $4.87 billion in ten years. The high adoption rates for rodent models stem from their genetic mutability and physiological similarities to humans, making them favorable for preclinical testing.

Animal Model Market Analysis By Type

Global Animal Model Market, By Type Market Analysis (2023 - 2033)

Genetically modified models led the market in 2023, holding a revenue share of 60.55% at approximately $8.66 billion. They are projected to reach $21.51 billion by 2033, fueled by advancements in genetic engineering. Wild-type models, with a 26.74% share translating to $3.82 billion, are projected to grow to $9.50 billion. Syndromic models represent a niche portion at 12.71%, starting at $1.82 billion in 2023 and expected to rise to $4.52 billion.

Animal Model Market Analysis By End User

Global Animal Model Market, By End-User Market Analysis (2023 - 2033)

Pharmaceutical companies dominate the Animal Model market with a significant share of 60.55%, amounting to $8.66 billion in 2023, forecasted to reach $21.51 billion by 2033. Academic institutions hold a 26.74% market share valued at $3.82 billion, projected to grow to $9.50 billion. CROs occupy the remaining 12.71% with $1.82 billion and are expected to reach $4.52 billion within the same timeframe.

Animal Model Market Analysis By Application

Global Animal Model Market, By Application Market Analysis (2023 - 2033)

Oncology is the leading application area, holding a market share of 50.82% at $7.27 billion, escalating to $18.06 billion by 2033. Neurology follows with 24.54%, valued at $3.51 billion, projected to grow to $8.72 billion. Immunology stands at $1.67 billion (11.7% share) in 2023, aiming for $4.16 billion, while toxicology represents 12.94% of the market, starting at $1.85 billion and expected to reach $4.60 billion.

Animal Model Market Trends and Future Forecast

The Animal Model market is expected to continue its upward trajectory, with projected growth to $75 billion by 2033. Significant trends include the increasing utilization of genetically modified models, rising ethical concerns driving demand for advanced alternative methods, and enhanced technology adoption such as AI in data analysis. Moreover, collaboration between academia and industry will spur innovation in model development. Challenges such as ethical scrutiny and regulatory hurdles may pose risks to growth but are expected to be mitigated by technological improvements and greater awareness of animal welfare.

Request a custom research report for industry.

Global Market Leaders and Top Companies in Animal Model Industry

Charles River Laboratories:

A leading global provider of animal model services and products, Charles River Laboratories specializes in research models, preclinical testing, and drug development services.

Janvier Labs:

Janvier Labs offers a variety of genetically modified and standard animal models for research, emphasizing the importance of robust animal welfare practices in compliance with regulations.

Envigo:

Envigo provides integrated research services and reliable high-quality animal models, focusing on various applications such as pharmacology, toxicology, and general biology.

Taconic Biosciences:

Taconic Biosciences is recognized for its expertise in breeding and supplying genetically engineered mouse models, catering primarily to the needs of the biopharmaceutical industry.

We're grateful to work with incredible clients.

Datasite
Agilent
Asten Johnson
Bio-Rad
Carl Zeiss
Dywidag
Illumina
LEK Consulting
Shell

Related Industries

    FAQs